APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
To access this article, please choose from the options below
PII: S0169-5002(09)00118-4
doi:10.1016/j.lungcan.2009.02.019
© 2009 Elsevier Ireland Ltd. All rights reserved.
